Meloxicam is the recommended analgesic in the CWMP and is a non-steroidal anti-inflammatory drug (NSAID). But unlike the other NSAID medications that inhibit platelet function and can lead to increased bleeding risk, it is a preferential COX-2 inhibitor that spares platelet function so it does not interfere with hemostasis and is well-tolerated.
- The proper dosage for meloxicam is 15 mg PO daily.
- The route of administration is PO.
- Meloxicam is for mild to moderate pain management in a casualty that is still able to fight.
- Contraindications include NSAID or salicylate hypersensitivity, asthma, and severe renal or hepatic disease. Potential benefits may warrant use of the drug in pregnant women despite potential risks if the alternative is worse.
- Potential side effects include edema, flu-like syndrome, abdominal pain, diarrhea, dyspepsia, nausea, ulceration, GI bleed, anemia, headache, or insomnia.
- There may be a decreased effect of ACE inhibitors and diuretics, increased lithium levels and toxicity, increased GI bleed risk with aspirin and warfarin.
- The Onset/Peak/Duration for meloxicam is 30-60 min/5-6 hr/20-24 hr.
- There is minimal to no mission impact.
- Do not give to K-9 casualties.